The Transformative Role of Artificial Intelligence in Pharmaceutical Innovation and Biomedical Studies

This paper focuses on the influence of artificial intelligence (AI) in the process of new drug development and in the treatment of diseases. Based on the literature review of the last five years, we present the broad range of AI applications ranging from drug discovery, screening to regulatory aspects, drug designing, and delivery. Leveraging of AI firms by pharmaceutical companies has seen more effective drug development thus improving the global health care systems. Virtual screening and design with the use of AI allow expanding the concept of traditional medicine and enable the search for new drugs in combined molecular structures. Furthermore, the application of AI in pharmaceutical regulatory affair seems significant in enhancing efficiency and compliance. The synthesized nanocarriers with the help of AI technologies are highly precise to have an accurate targeting system in treatments which enhances its effectiveness and the quality of life of the patients. More changes in regards to drug designing, discovering along with the compliance to regulatory benchmarks will be seen in the near future with the mounting popularity of the AI among the sectors of the pharmaceutical industries.